Announced
Completed
ELLIPSE TECHNOLOGIES INC / NUVASIVE INC / WEXFORD CAPITAL / MEDFOCUS FUND LLC / HBM BIOVENTURES AG / BIOSTAR VENTURES LLC / Acquisition / Public / £278m
Synopsis
Sale of Ellipse Technologies, a developer of minimally invasive treatments for spinal deformities, to NuVasive.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite